Pelthos Therapeutics (PTHS) Other Working Capital Changes (2026)

Pelthos Therapeutics (PTHS) posted Other Working Capital Changes of -$424000.0 for Q2 2026, down 75.93% on a QoQ basis from -$241000.0 in Q1 2026.

Analysis

Pelthos Therapeutics (PTHS) Other Working Capital Changes (2026) Analysis & Trends

Pelthos Therapeutics has reported Other Working Capital Changes for 2 years, with the latest figure at -$330000.0 in Q2 2026.

On a quarterly basis, Other Working Capital Changes changed N/A year-over-year to -$424000.0 in Q2 2026; TTM through Jun 2026 was -$665000.0, a N/A change from a year earlier, with the FY2025 full-year figure at -$589000.0, changed N/A from the prior year.
Other Working Capital Changes was -$330000.0 for Q2 2026 at Pelthos Therapeutics, down from -$163000.0 in the prior quarter.
The five-year high for Other Working Capital Changes was -$93000.0 in Q4 2025, with the low at -$330000.0 in Q2 2026.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Johnson & Johnson	642.34 Bn	621.58 Bn	17.26 Bn
2	AbbVie	446.74 Bn	440.17 Bn	12.70 Bn
3	Merck	357.89 Bn	350.75 Bn	12.21 Bn
4	Novartis Ag	267.44 Bn	259.75 Bn	11.24 Bn
5	Pfizer	156.55 Bn	144.85 Bn	10.94 Bn
6	Sanofi	52.21 Bn	44.83 Bn	10.79 Bn
7	Revolution Medicines	42.85 Bn	42.85 Bn	-
8	Incyte	24.63 Bn	20.09 Bn	1.57 Bn
9	United Therapeutics	21.40 Bn	18.74 Bn	683.80 Mn
10	Pelthos Therapeutics	80.13 Mn	55.57 Mn	21.23 Mn

Historic Data

Download Data